Skip to main content

Table 2 Profile of protein spots detected in leiomyomas from Caucasians and African Americans

From: Genomic and proteomic profiling I: Leiomyomas in African Americans and Caucasians

Tissue

Increased Intensity

Decreased Intensity

Not Changed

Not-Detected

Fibroid-315C

31 (1.7–8.90 fold)

289 (1.5–48.80 fold)

-----

 

Fibroid-316C

42 (1.5–13.2 fold)

171 (1.5–46.00 fold)

61

55

Fibroid-317C

129 (1.5–14.8 fold)

135 (1.5–128.7 fold)

3

64

Fibroid-344AA

180 (1.5–41.6 fold)

62 (1.5–37.70 fold)

7

81

Fibroid-353AA

81 (1.5–35.3 fold)

100 (1.5–86.80 fold)

33

118

Fibroid-357AA

80 (1.5–14.1 fold)

65 (1.5–38.20 fold)

22

165

  1. The number of protein spots detected in leiomyomas from Caucasians (315C, 316C and 317C) and African Americans (334AA, 353AA and 357AA) as compared to protein spots detected in myometrium of 315C used for normalization. Total number of spots detected in myometrium #315 was 332. The column shows the number of spots whose intensity increased, decreased, not changed (± 1.5 fold), or not detected as compared to myometrium #315C. The range of difference in protein spot intensity is shown as fold change as compared to their intensity in myometrium 315C.